Ledger.Open graph →
SEC Form D · filed November 22, 2023

Alcyone Therapeutics, Inc

Offering
$31.6M
Sold
$17.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
LOWELL, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

David Donabedian · Lowell, MADirectorSanjay Pal · Seattle, WAExec · DirectorTommi Unkuri · STOCKHOLM, V7DirectorCameron Durrant · Lowell, MADirectorEdgar D. Jannotta · Lowell, MADirectorHeath Wilson · Knoxville, TNDirectorPj Anand · Lowell, MAExec · DirectorNorbert D. Riedel · Lowell, MADirectorRichard Upton · Lowell, MADirectorEdgar D. Jannotta · Lowell, MADirectorLarry Page · Seattle, WADirectorJoseph Odom · Knoxville, TNDirectorStephen D. Oesterle · Lowell, MADirectorReynir G. Indahl · STOCKHOLM, V7DirectorStephen D. Oesterle · Lowell, MADirectorNorbert D. Riedel · Lowell, MADirectorChristian Melby · STOCKHOLM, V7DirectorPj Anand · Lowell, MAExec · DirectorDavid Donabedian · Lowell, MADirectorCameron Durrant · Lowell, MADirectorRichard Upton · Lowell, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗